Celdyque

Strip away the founder mythology that usually opens a brand history and you are left with the label itself, which is, fittingly, the entire point of this one. Every product is named for a single percentage: an azelaic acid pegged at twelve percent, a niacinamide serum at twenty, a bakuchiol concentrate quoted in parts per million, a glutathione serum, a retinal-and-retinol pairing. This is a deliberate response to a category fatigued by vague 'glow' and 'radiance' promises, aimed at shoppers who have learned to read an ingredient list and want the dosage printed where the marketing copy used to be. The formulation logic is consistent across the range: lead with one well-characterized active at a concentration that does meaningful work, strip out fragrance and common fillers, then buffer the active with soothing supporting players like centella asiatica, ceramide NP, and adenosine so the higher percentages stay tolerable on sensitive skin. That last move matters, because a twelve-percent azelaic or a twenty-percent niacinamide can sting or flush if delivered without a calming base; user feedback on the azelaic serum specifically notes meaningful fading of post-inflammatory marks without the burn that often accompanies the ingredient. The catalog rounds out with a gentle cleanser meant to sit upstream of the actives rather than compete with them. The hard truth is documentation: the people, the ownership structure, and the precise launch behind the brand simply are not recorded in reliable English-language sources, and it surfaced in international retail and editorial roundups only recently. There is no independent clinical validation to lean on. So the brand has to be judged the way it asks to be judged, on the legibility and sensibility of its formulas, with the standing caveat of a very short, unproven track record.

Sources:[1][2][3]